Alice Prince Editor 2013 Bacterial pneumonia or lower respiratory tract infection is a major cause of morbidity and mortality worldwide, affecting diverse patient populations ranging from infants to the elderly; previously healthy individuals as well as those with major immunological de fi ciencies—genetic and acquired. Pneumonia results in a tremendous economic burden estimated at 40.2 billion dollars in the […]
Continue reading →
Muhammad Munir • Siamak Zohari Mikael Berg 2013 I am delighted to have been asked to write the foreword for this book. The authors Muhammad Munir, Siamak Zohari, and Mikael Berg are well-qualified veterinary virologists with extensive experience on the Peste des Petite Ruminants Virus (PPRV). They have done an excellent job addressing the aspects of the PPRV research […]
Continue reading →
Piero Manfredi • Alberto d’Onofrio Editors 2013 This book is about the rather new discipline of “behavioral epidemiology” of infectious diseases (BE). And “behavioral epidemiology” was indeed the title we originally planned to give this book when its first ideas were grown. Unfortunately, we have discovered soon after that the description “behavioral epidemiology” is quite common in other areas […]
Continue reading →
Lorenzo Emmi 2013 Perché un libro sulle malattie rare? E poi, su quale malattia rara? Sono davvero importanti? Sono sempre gravi? Sono tutte genetiche? Queste e altre le domande che credo possano porsi tanti pazienti e medici che entrano a contatto con questo grande e apparentemente sterminato universo. Intanto, per cercare di fare un po’ d’ordine, si definisce rara […]
Continue reading →
Jos A. Bosch • Anna C. Phillips • Janet M. Lord Editors 2013 The post-WorldWar II generation of babies born in the USA between 1946 and 1964 began to reach their 65th birthday earlier this year. This explosion in births, amounting to 76 million American children, temporarily stemmed the tide in the USA’s declining birth rate. Similarly, most […]
Continue reading →
G. Singh Chhatwal Editor 2013 Streptococci are Gram-positive bacteria capable of causing a wide spectrum of diseases in humans and animals. Group A streptococci (Streptococcus pyogenes) are exclusively human pathogenic bacteria. Group C and group G streptococci, which were traditionally considered as animal pathogenic bacteria, are emerging as causative organisms of human diseases. The diseases caused by streptococci range from […]
Continue reading →
Li Wu ● Olivier Schwartz Editors 2013 We are excited to introduce this book as an addition to a new series, Topics in HIV and AIDS Research . We expect that this volume and other important topics of the book series ef fi ciently promote basic and clinical research of HIV and AIDS in a timely fashion. In […]
Continue reading →
Ralf Bartenschlager Editor 2013 Hepatitis C has long been regarded as the ‘silent epidemic’. Although there is some truth in this statement that reflects the mostly asymptomatic course of infection and the low perception of the disease in the general public, the situation has changed profoundly in the last couple of years. On one hand this is due […]
Continue reading →
Massoud Mahmoudi Editor 2013 Allow me to present Challenging Cases in Rheumatology and Diseases of the Immune System . This book, like our three preceding titles, Challenging Cases in Allergy and Immunology (2009), Challenging Cases in Allergic and Immunologic Diseases of the Skin (2010), and Challenging Cases in Pulmonology (2011), presents the topic in a case-based study format. Rheumatology is […]
Continue reading →
Jean-Louis Prugnaud Jean-Hugues Trouvin Editors 2013 Biological medicinal products including biotechnology-derived medicinal products (often referred to as ‘‘biologicals’’) have an impressive record in treating numerous serious diseases, and their market is growing faster than that of all pharmaceuticals combined. Insulin produced by using recombinant DNA technology was the first approved therapeutic protein. It entered the US market in October 1982 […]
Continue reading →